# Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp

> **NCT01583582** · PHASE2 · COMPLETED · sponsor: **Marealis AS** · enrollment: 74 (actual)

## Conditions studied

- Hypertension
- Blood Pressure

## Interventions

- **DIETARY_SUPPLEMENT:** Marealis Refined Peptide Concentrate
- **DIETARY_SUPPLEMENT:** Marealis Refined Peptide Concentrate
- **DIETARY_SUPPLEMENT:** Marealis Refined Peptide Concentrate

## Key facts

- **NCT ID:** NCT01583582
- **Lead sponsor:** Marealis AS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01583582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01583582, "Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01583582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*